Stephen Blakemore
Vice President, Biological & Translational Sciences @ Accent Therapeutics
jf9z6p0001@fivgwyhv.96q
Sign up to see email
Known information
- Holds a PhD
- Specializes in Biological & Translational Sciences
About Accent Therapeutics
Accent Therapeutics, based in Lexington, MA, develops small molecule therapeutics targeting RNA-modifying proteins for cancer treatment. The company has a partnership with AstraZeneca and has raised $75 million in Series C financing.